Jeffrey V. Poulton, EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 4,403 shares at $449.92 ($2.0M) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Open-market sale of $2.0M ALNY by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $447.98 | 63 | $28K | 1.4% |
| 2 | $449.92 | 147 | $66K | 3.3% |
| 3 | $449.92 | 147 | $66K | 3.3% |
| 4 | $450.92 | 63 | $28K | 1.4% |
| 5 | $451.99 | 168 | $76K | 3.8% |
| 6 | $451.99 | 168 |
| $76K |
| 3.8% |
| 7 | $452.96 | 536 | $243K | 12.2% |
| 8 | $452.96 | 536 | $243K | 12.2% |
| 9 | $454.04 | 886 | $402K | 20.2% |
| 10 | $454.04 | 886 | $402K | 20.2% |
| 11 | $454.84 | 392 | $178K | 8.9% |
| 12 | $454.84 | 392 | $178K | 8.9% |
| 13 | $455.82 | 19 | $9K | 0.4% |
| Total | $453.36 avg | 4,403 | $2.0M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $1.0M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $3.4M | — | Filing → |